Celsion (CLSN) COVID Vaccine Effective in Pre-Clinical Studies

Published on September 3, 2021

Celsion (CLSN) announces data from pre-clinical studies for its investigational vaccine platform as a potential treatment for COVID-19.

Continue reading on website
Other news

6 Ways to Make a Bad First Impression During Business Outreach

September 3, 2021
Cold calling is not for everyone -- and that's where automated outreach comes in. But what is the impact on your brand?

Apple Announces $30 Million Investment Towards Racial Equity Focusing on Hispanic Inclusion

September 3, 2021
The investment will support new initiatives through Apple's Racial Equity and Justice Initiative.